Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis

Archives of Neurology

Volumn 59, Issue 5, 2002, Pages 774-780

  Gelati, Maurizio ^a   Corsini, Elena ^a   De Rossi, Marco ^a   Masini, Laura ^a   Bernardi, Gaetano ^a   Massa, Giorgio ^a   Boiardi, Amerigo ^a   Salmaggi, Andrea ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GELATINASE A; GELATINASE B; METHYLPREDNISOLONE; MONOKINE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CELL KINETICS; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0036094479     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.5.774     Document Type: Article

References (27)

1. Lymphocyte migration and multiple sclerosis: Relation with disease and therapy
2. Adhesion molecules in multiple sclerosis
3. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule
4. Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system
5. Chemokines
6. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
7. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium
8. The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions
9. Reduced adhesion of PBMNCs to endothelium in methylprednisolone-treated MS patients: Preliminary results
10. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria
11. Rating neurologic impairment in multiple sclerosis: An expanded disability scale (EDSS)
12. Methylprednisolone infusion during acute exacerbation of MS: Plasma and CSF concentrations
13. Identification of subsets of human T cells capable of enhanced transendothelial migration
14. Cytokine regulation of human microglial cell IL-8 production
15. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas
16. Oral contraceptives that contain ethinyl estradiol (0.0035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers
17. Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS
18. In vitro effects of high- and low-dose methylprednisolone on HLA-DR, ICAM-1 and VCAM-1 on human microvascular cerebral endothelium
19. Chemokines and leukocytes traffic
20. Expression and modulation of interferon gamma inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: Possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis
21. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
22. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
23. Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9
24. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brainbarrier injury
25. Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis
26. Immunological markers in multiple sclerosis
27. Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis